• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
Menu
GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
    • Medical Device
      • Philippine Essential Medical Device List
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
  • AUXILIARY MENU
  • GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
    • Medical Device
      • Philippine Essential Medical Device List
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer

Process of Patient Referral to COVID 19 Clinical Trials

  • admin
  • April 15, 2021
  • 2:17 pm
Department Memorandum 2021-0171

Related Posts

  • cOvid 19 Updates

    16 Nov 2020
  • DOH Steering Committee for the Clinical Trials for COVID-19

    07 Oct 2020
  • Policy Dialogue on Universal Healthcare and Access to Medicines

    11 Oct 2020
April 2021
M T W T F S S
 1234
567891011
12131415161718
19202122232425
2627282930  
« Mar   Jun »
PrevPreviousGovernment-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav Preparations
NextIssuances and Information on the Antimicrobial Stewardship (AMS) Blended Learning Program Framework for HospitalsNext

Philippine Standard time

Contact Us:

Telephone Number: 02-8757734 Loc. 253

Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City

Email Address: dohncpam@gmail.com

Related Links:

Drug Price Reference Index (DPRI)

Inter-agency Committee on Antimicrobial Resistance (ICAMR)

Drug Price Watch (DPW)

Health Technology Assessment Unit (HTAU)

Related Links (For DOH Personnel only):

Electronic Drug Price Monitoring System (EDPMS)

Pharmaceutical Management Information System (PMIS)